The global antiemetics market share is expected to witness exponential growth rate during the foreseeable time frame. This growth can be primarily credited to rising number of patients diagnosed with cancer disease. Moreover, extensive research being carried out to modernize antiemetic drug therapy will further improve the industry size.
Identification of novel drug targets and usage of new drug delivery to improve compliance of patients are the additional factors contributing significantly in the industry growth rate between 2019 and 2025. However, the antiemetics drugs in clinical phase needs more advancement for commercializing the product. Also, lack of animal model to accurately mimic the human responses for the therapy may restrict the industry growth.
Global antiemetics market is segregated on the basis of drug as, 5-HT3 receptor antagonists, Dopamine antagonists, NK1 receptor antagonist, Antihistamines, Cannabinoids, Benzodiazepines, Anticholinergics, Steroids, and others. Based on application, the global antiemetics market is segmented as Chemotherapy, Motion Sickness, Gastroenteritis, General Anaesthetics, Opioid Analgesics, Dizziness, Pregnancy, Food Poisoning, Emotional Stress, and others.
Global antiemetics market report provides geographic analysis covering regions such as North America, Europe, Asia Pacific, and Rest of World. The antiemetics market for each region is further segmented for major countries including U.S., Canada, Germany, UK, France, Italy, China, India, Japan, Brazil, South Africa and others.
Competitive Rivalry
Eli Lilly and Company, Bristol-Myers Squibb, Merck, GlaxoSmithKline, Sanofi-Aventis, Pfizer, Astellas Pharma, Baxter International, and Johnson & Johnson are among the major players in the global antiemetics market share. The companies are involved in several growth and expansion strategies to gain a competitive advantage. Industry participants also follow value chain integration with business operations in multiple stages of the value chain.
The Antiemetics Market has been segmented as below:
Antiemetics Market, By Drug
Antiemetics Market, By Application
Antiemetics Market, By Region
The report covers:
Report scope:
Global antiemetics market report scope includes detailed study covering underlying factors influencing the industry trends.
The report covers analysis on regional and country level market dynamics. The scope also covers competitive overview providing company market shares along with company profiles for major revenue contributing companies.
The report scope includes detailed competitive outlook covering market shares and profiles key participants in the global antiemetics market share. Major industry players with significant revenue share include Eli Lilly and Company, Bristol-Myers Squibb, Merck, GlaxoSmithKline, Sanofi-Aventis, Pfizer, Astellas Pharma, Baxter International, and Johnson & Johnson.
Reasons to Buy this Report:
Customization:
Customized report as per the requirement can be offered with appropriate recommendations
Below are our New Reports :-
1. Introduction
1.1. Key Points
1.2. Report Description
1.3. Markets Covered
1.4. Stakeholders
2. Research Methodology
2.1. Research Scope
2.2. Research Methodology
2.2.1. Market Research Process
2.2.2. Research Methodology
2.2.2.1. Secondary Research
2.2.2.2. Primary Research
2.2.2.3. Models for Estimation
2.3. Market Size Estimation
2.3.1. Bottom-Up Approach
2.3.2. Top-Down Approach
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Drivers
4.2.1. Extensive research activities
4.2.2. Use of novel drug delivery to improve patient compliance
4.3. Restraints
4.3.1. Lack of suitable animal model
4.4. Opportunities
4.4.1. Identification of new drug targets
4.4.2. Novel drug therapies
4.5. Challenges
4.5.1. Availability of alternative treatments
4.5.2. Pricing pressure experienced by innovators
5. Antiemetics Market, By Drug
5.1. Key Points
5.2. Chemotherapy
5.3. Motion sickness
5.4. Gastroenteritis
5.5. General anaesthetics
5.6. Opioid analgesics
5.7. Dizziness
5.8. Pregnancy
5.9. Food poisoning
5.10. Emotional stress
5.11. Others
6. Antiemetics Market, By Application
6.1. Key Points
6.2. Chemotherapy
6.3. Motion sickness
6.4. Gastroenteritis
6.5. General anaesthetics
6.6. Opioid analgesics
6.7. Dizziness
6.8. Pregnancy
6.9. Food poisoning
6.10. Emotional stress
6.11. Others
7. Competitive Landscape
7.1. Introduction
7.2. Recent Developments
7.2.1. Mergers & Acquisitions
7.2.2. New Product Developments
7.2.3. Portfolio/Production Capacity Expansions
7.2.4. Joint Ventures, Collaborations, Partnerships & Agreements
7.2.5. Others
8. Company Profile
8.1. Eli Lilly and Company
8.1.1. Company Overview
8.1.2. Product/Service Landscape
8.1.3. Financial Overview
8.1.4. Recent Developments
8.2. Bristol-Myers Squibb
8.2.1. Company Overview
8.2.2. Product/Service Landscape
8.2.3. Financial Overview
8.2.4. Recent Developments
8.3. Merck
8.3.1. Company Overview
8.3.2. Product/Service Landscape
8.3.3. Financial Overview
8.3.4. Recent Developments
8.4. GlaxoSmithKline
8.4.1. Company Overview
8.4.2. Product/Service Landscape
8.4.3. Financial Overview
8.4.4. Recent Developments
8.5. Sanofi-Aventis
8.5.1. Company Overview
8.5.2. Product/Service Landscape
8.5.3. Financial Overview
8.5.4. Recent Developments
8.6. Pfizer
8.6.1. Company Overview
8.6.2. Product/Service Landscape
8.6.3. Financial Overview
8.6.4. Recent Developments
8.7. Astellas Pharma
8.7.1. Company Overview
8.7.2. Product/Service Landscape
8.7.3. Financial Overview
8.7.4. Recent Developments
8.8. Baxter International
8.8.1. Company Overview
8.8.2. Product/Service Landscape
8.8.3. Financial Overview
8.8.4. Recent Developments
8.9. Johnson & Johnson
8.9.1. Company Overview
8.9.2. Product/Service Landscape
8.9.3. Financial Overview
8.9.4. Recent Developments
The Antiemetics Market has been segmented as below:
Antiemetics Market, By Drug
Antiemetics Market, By Application
Antiemetics Market, By Region
SUBSCRIBE TO OUR NEWSLETTERS
